Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Byrd

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Leukemia|June 21, 2014
Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemiaR Mani, Y Mao, F W Frissora, et al.
Leukemia|January 25, 2017
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemiaE J Murphy, D S Neuberg, L Z Rassenti, et al.
Leukemia|June 22, 2016
Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignanciesZ A Hing, H Y J Fung, P Ranganathan, et al.
Leukemia|March 16, 2007
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemiaA C Rawstron, N Villamor, M Ritgen, et al.
Leukemia|November 27, 2012
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemiaA Mims, A R Walker, X Huang, et al.
Leukemia|May 13, 2014
Circulating miRNA markers show promise as new prognosticators for multiple myelomaA Rocci, C C Hofmeister, S Geyer, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Leukemia|June 21, 2014
Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemiaR Mani, Y Mao, F W Frissora, et al.
Leukemia|January 25, 2017
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemiaE J Murphy, D S Neuberg, L Z Rassenti, et al.
Leukemia|June 22, 2016
Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignanciesZ A Hing, H Y J Fung, P Ranganathan, et al.
Leukemia|March 16, 2007
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemiaA C Rawstron, N Villamor, M Ritgen, et al.
Leukemia|November 27, 2012
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemiaA Mims, A R Walker, X Huang, et al.
Leukemia|May 13, 2014
Circulating miRNA markers show promise as new prognosticators for multiple myelomaA Rocci, C C Hofmeister, S Geyer, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
Pageof 19